NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
Release Date:
In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podcast. In this episode, Dr. Robertson presents an overview of NMOSD treatment, including goals, triggers, and considerations for switching therapies.
DA-UNBR-US-02296-2 05/2024
Sponsored by Horizon Therapeutics
NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies